Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression

Abstract Emerging evidence suggests that metformin, an activator of AMP-activated protein kinase (AMPK), may be useful in preventing and treating pancreatic ductal adenocarcinoma (PDAC). However, whether metformin has an effect on the stromal reaction of PDAC remains unknown. In this study, we first...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2017-01, Vol.385, p.225-233
Hauptverfasser: Duan, Wanxing, Chen, Ke, Jiang, Zhengdong, Chen, Xin, Sun, Liankang, Li, Jiahui, Lei, Jianjun, Xu, Qinhong, Ma, Jiguang, Li, Xuqi, Han, Liang, Wang, Zheng, Wu, Zheng, Wang, Fengfei, Wu, Erxi, Ma, Qingyong, Ma, Zhenhua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!